Warning: The NCBI web site requires JavaScript to function. more...
Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease.
Su B, Liu H, Wang X, Chen SG, Siedlak SL, Kondo E, Choi R, Takeda A, Castellani RJ, Perry G, Smith MA, Zhu X, Lee HG.
Mol Neurodegener. 2009 Jul 23;4:32.
Related citations
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M.
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73.
Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM.
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2047-52. Epub 2003 Feb 7.
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gómez C, Ambrosio S.
J Neural Transm. 2001;108(12):1383-96.
The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K, Domingo-Sàbat M, Santos C, Tolosa E, Ferrer I, Ariza A.
Brain. 2010 Dec;133(Pt 12):3724-33. Epub 2010 Oct 19.
Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A, Engelender S.
Cell Cycle. 2006 Sep;5(18):2082-6. Epub 2006 Sep 15. Review.
Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.
Welander H, Bontha SV, Näsström T, Karlsson M, Nikolajeff F, Danzer K, Kostka M, Kalimo H, Lannfelt L, Ingelsson M, Bergström J.
Biochem Biophys Res Commun. 2011 Aug 19;412(1):32-8. Epub 2011 Jul 21.
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7.
Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains.
van Horssen J, de Vos RA, Steur EN, David G, Wesseling P, de Waal RM, Verbeek MM.
J Alzheimers Dis. 2004 Oct;6(5):469-74.
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S.
Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.
Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments.
Jensen PH, Islam K, Kenney J, Nielsen MS, Power J, Gai WP.
J Biol Chem. 2000 Jul 14;275(28):21500-7.
Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E, Gonzalo I, Newell K, García Yébenes J, Vonsattel P, Hyman BT.
Acta Neuropathol. 2002 May;103(5):495-500. Epub 2002 Feb 23.
The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
Schulz-Schaeffer WJ.
Acta Neuropathol. 2010 Aug;120(2):131-43. Epub 2010 Jun 20. Review.
Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.
Lee SS, Kim YM, Junn E, Lee G, Park KH, Tanaka M, Ronchetti RD, Quezado MM, Mouradian MM.
Neurobiol Aging. 2003 Sep;24(5):687-96.
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M.
Neurosci Lett. 1998 Jul 31;251(3):205-8.
Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S.
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5500-5. Epub 2004 Apr 2.
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG, Goedert M.
Ann N Y Acad Sci. 2000;920:16-27. Review.
Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.
Brain Res. 1999 Oct 2;843(1-2):53-61.
Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T.
Acta Neuropathol. 2002 Sep;104(3):225-30. Epub 2002 May 9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on